SCHEMBL4894905

SCHEMBL4894905

CCc1ccc2c(c1)Cc1cc(CC)ccc1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 2/20 0.46
ATM Q13315 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RAB9A P51151 6/20 0.45
NPC1 O15118 5/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TRPA1 O75762 1/20 0.43
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 1/20 0.41
TP53 P04637 1/20 0.41
PDK2 Q15119 1/20 0.40
CYP17A1 P05093 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5357579 0.90 ALDH1A1 (0.59) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL23759836 0.88 METAP1 (0.43) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL4896965 0.86 ALDH1A1 (0.45) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL15457995 0.85 LMNA (0.40) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL26778595 0.85 ALDH1A1 (0.55) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL1906502 0.83 MMP12 (0.43) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL11845877 0.82 RAB9A (0.74) ALDH1A1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL6906334 0.82 CYP1A2 (0.48) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL29737067 0.82 CYP1A2 (0.48) ALDH1A1TSHRATMNPSR1RAB9A
SCHEMBL4900256 0.82 CNR1 (0.50) ALDH1A1TSHRATMNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084559-B2 Ethylene-vinylcyclohexane copolymers SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-27 US disclosed
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) 2008-07-03 US disclosed
CN-101107260-A Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer SUMITOMO CHEMICAL CO (JP) 2008-01-16 CN disclosed
CN-1227271-C Solid catalytic composition for olefin polymerization ATOCHEM ELF SA (FR) 2005-11-16 CN disclosed
EP-0889065-B1 Solid catalyst component for the polymerisation of olefins ATOFINA (FR) 2001-08-22 EP disclosed
EP-0666267-B1 Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM CO (US) 2001-04-18 EP disclosed
US-6057258-A Solid catalytic component for the polymerization of olefins ELF ATOCHEM S.A. (FR) 2000-05-02 US disclosed
EP-0889065-A1 Solid catalyst component for the polymerisation of olefins ELF ATOCHEM S.A. (FR) 1999-01-07 EP disclosed
CN-1203924-A Solid catalytic composition for olefin polymerization ATOCHEM ELF SA (FR) 1999-01-06 CN disclosed
US-5571880-A CATALYSTS FOR POLYMERIZATION OF OLEFINS ESPECIALLY TO OBTAIN SYNDIOTACTIC POLYMERS PHILLIPS PETROLEUM COMPANY (US) 1996-11-05 US disclosed
EP-0666267-A2 Organometallic fluorenyl compounds, preparation, and use PHILLIPS PETROLEUM COMPANY (US) 1995-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer AOC2, ACSL1, ACSL3 ALDH1A1 1292/4885TSHR 3725/4885ATM 2905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.